Notice2023-27069
National Cancer Institute; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 11, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 236 (Monday, December 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 236 (Monday, December 11, 2023)]
[Notices]
[Page 85896]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-27069]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis, Panel SEP-1: NCI Clinical and
Translational Cancer Research, February 7, 2024, 9:00 a.m. to February
7, 2024, 5:00 p.m., National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland, 20850 which was
published in the Federal Register on November 17, 2023, FR Doc. 2023-
25490, 88 FR 80322.
This notice is being amended to change the meeting date from
February 7, 2024, to February 20, 2024. The meeting location and time
will stay the same. The meeting is closed to the public.
Dated: December 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-27069 Filed 12-8-23; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on December 11, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.